BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 24875537)

  • 1. Inhibition of dihydroceramide desaturase activity by the sphingosine kinase inhibitor SKI II.
    Cingolani F; Casasampere M; Sanllehí P; Casas J; Bujons J; Fabrias G
    J Lipid Res; 2014 Aug; 55(8):1711-20. PubMed ID: 24875537
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proteasomal degradation of sphingosine kinase 1 and inhibition of dihydroceramide desaturase by the sphingosine kinase inhibitors, SKi or ABC294640, induces growth arrest in androgen-independent LNCaP-AI prostate cancer cells.
    McNaughton M; Pitman M; Pitson SM; Pyne NJ; Pyne S
    Oncotarget; 2016 Mar; 7(13):16663-75. PubMed ID: 26934645
    [TBL] [Abstract][Full Text] [Related]  

  • 3. From Sphingosine Kinase to Dihydroceramide Desaturase: A Structure-Activity Relationship (SAR) Study of the Enzyme Inhibitory and Anticancer Activity of 4-((4-(4-Chlorophenyl)thiazol-2-yl)amino)phenol (SKI-II).
    Aurelio L; Scullino CV; Pitman MR; Sexton A; Oliver V; Davies L; Rebello RJ; Furic L; Creek DJ; Pitson SM; Flynn BL
    J Med Chem; 2016 Feb; 59(3):965-84. PubMed ID: 26780304
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dihydroceramide desaturase inhibitors induce autophagy via dihydroceramide-dependent and independent mechanisms.
    Casasampere M; Ordóñez YF; Casas J; Fabrias G
    Biochim Biophys Acta Gen Subj; 2017 Feb; 1861(2):264-275. PubMed ID: 27894925
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel mode of action of the putative sphingosine kinase inhibitor 2-(p-hydroxyanilino)-4-(p-chlorophenyl) thiazole (SKI II): induction of lysosomal sphingosine kinase 1 degradation.
    Ren S; Xin C; Pfeilschifter J; Huwiler A
    Cell Physiol Biochem; 2010; 26(1):97-104. PubMed ID: 20502009
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Dansyl-Modified Sphingosine Kinase Inhibitor DPF-543 Enhanced De Novo Ceramide Generation.
    Shamshiddinova M; Gulyamov S; Kim HJ; Jung SH; Baek DJ; Lee YM
    Int J Mol Sci; 2021 Aug; 22(17):. PubMed ID: 34502095
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sphingosine kinase inhibitors decrease viability and induce cell death in natural killer-large granular lymphocyte leukemia.
    LeBlanc FR; Liu X; Hengst J; Fox T; Calvert V; Petricoin EF; Yun J; Feith DJ; Loughran TP
    Cancer Biol Ther; 2015; 16(12):1830-40. PubMed ID: 26252351
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of the effect of sphingosine kinase inhibitors on apoptosis,unfolded protein response and autophagy of T-cell acute lymphoblastic leukemia cells; indications for novel therapeutics.
    Evangelisti C; Evangelisti C; Teti G; Chiarini F; Falconi M; Melchionda F; Pession A; Bertaina A; Locatelli F; McCubrey JA; Beak DJ; Bittman R; Pyne S; Pyne NJ; Martelli AM
    Oncotarget; 2014 Sep; 5(17):7886-901. PubMed ID: 25226616
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A sphingosine kinase inhibitor combined with temozolomide induces glioblastoma cell death through accumulation of dihydrosphingosine and dihydroceramide, endoplasmic reticulum stress and autophagy.
    Noack J; Choi J; Richter K; Kopp-Schneider A; Régnier-Vigouroux A
    Cell Death Dis; 2014 Sep; 5(9):e1425. PubMed ID: 25255218
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of isoenzyme-selective inhibitors of human sphingosine kinases.
    Gao P; Peterson YK; Smith RA; Smith CD
    PLoS One; 2012; 7(9):e44543. PubMed ID: 22970244
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gamma-tocotrienol profoundly alters sphingolipids in cancer cells by inhibition of dihydroceramide desaturase and possibly activation of sphingolipid hydrolysis during prolonged treatment.
    Jang Y; Rao X; Jiang Q
    J Nutr Biochem; 2017 Aug; 46():49-56. PubMed ID: 28456081
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of the sphingosine kinase 1 selective inhibitor, PF-543 on arterial and cardiac remodelling in a hypoxic model of pulmonary arterial hypertension.
    MacRitchie N; Volpert G; Al Washih M; Watson DG; Futerman AH; Kennedy S; Pyne S; Pyne NJ
    Cell Signal; 2016 Aug; 28(8):946-55. PubMed ID: 27063355
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SphK1 inhibitor II (SKI-II) inhibits acute myelogenous leukemia cell growth in vitro and in vivo.
    Yang L; Weng W; Sun ZX; Fu XJ; Ma J; Zhuang WF
    Biochem Biophys Res Commun; 2015 May; 460(4):903-8. PubMed ID: 25824043
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and Biological Evaluation of BODIPY-PF-543.
    Shrestha J; Hwang GT; Lee T; Kim SW; Oh YS; Kwon Y; Hong SW; Kim S; Seop Moon H; Baek DJ; Park EY
    Molecules; 2019 Dec; 24(23):. PubMed ID: 31810327
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuroprotective role of sphingolipid rheostat in excitotoxic retinal ganglion cell death.
    Nakamura N; Honjo M; Yamagishi R; Kurano M; Yatomi Y; Watanabe S; Aihara M
    Exp Eye Res; 2021 Jul; 208():108623. PubMed ID: 34022173
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of the Sphingosine Kinase 1 Selective Inhibitor, PF543 on Dextran Sodium Sulfate-Induced Colitis in Mice.
    Sun M; Zhou Y; Shi Y; Liu B
    DNA Cell Biol; 2019 Nov; 38(11):1338-1345. PubMed ID: 31464523
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting sphingosine kinase-1 to inhibit melanoma.
    Madhunapantula SV; Hengst J; Gowda R; Fox TE; Yun JK; Robertson GP
    Pigment Cell Melanoma Res; 2012 Mar; 25(2):259-74. PubMed ID: 22236408
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The sphingosine kinase inhibitor 2-(p-hyroxyanilino)-4-(p-chlorophenyl)thiazole reduces androgen receptor expression via an oxidative stress-dependent mechanism.
    Tonelli F; Alossaimi M; Williamson L; Tate RJ; Watson DG; Chan E; Bittman R; Pyne NJ; Pyne S
    Br J Pharmacol; 2013 Mar; 168(6):1497-505. PubMed ID: 23113536
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibitors of dihydroceramide desaturase 1: Therapeutic agents and pharmacological tools to decipher the role of dihydroceramides in cell biology.
    Casasampere M; Ordoñez YF; Pou A; Casas J
    Chem Phys Lipids; 2016 May; 197():33-44. PubMed ID: 26248324
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of SKI-349, a dual-targeted inhibitor of sphingosine kinase and microtubule polymerization.
    Hengst JA; Hegde S; Paulson RF; Yun JK
    Bioorg Med Chem Lett; 2020 Oct; 30(20):127453. PubMed ID: 32736077
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.